Bellevue Life Sciences Acquisition Corp. Stock
Equities
BLAC
US0791741087
Investment Holding Companies
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.81 USD | +0.19% |
|
+0.46% | +2.95% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 95.08M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 * | - |
Net Debt 2022 | 1.09M | Net Debt 2023 | 56.58K | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
210
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.02% |
1 day | +0.19% | ||
1 week | +0.46% | ||
Current month | +0.46% | ||
1 month | +0.75% | ||
3 months | +1.31% | ||
6 months | +2.46% | ||
Current year | +2.95% |
![Extreme 10.76](/images/extremecours_fleche.png)
![Extreme 10.74](/images/extremecours_fleche.png)
![Extreme 10.5](/images/extremecours_fleche.png)
![Extreme 10.26](/images/extremecours_fleche.png)
![Extreme 10.07](/images/extremecours_fleche.png)
![Extreme 10.07](/images/extremecours_fleche.png)
![Extreme 10.07](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 20-07-31 |
Jin Park
BRD | Director/Board Member | 56 | 23-02-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 10.81 | +0.19% | 9,223 |
24-07-01 | 10.79 | +0.28% | 6,788 |
Delayed Quote Nasdaq, July 02, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+2.95% | 60.78M | |
+81.31% | 5.61B | |
+94.72% | 1.23B | |
+2.57% | 986M | |
+29.44% | 846M | |
+2.30% | 668M | |
+2.33% | 615M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock